These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24094552)

  • 1. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria.
    Sanayama Y; Nagasaka H; Takayanagi M; Ohura T; Sakamoto O; Ito T; Ishige-Wada M; Usui H; Yoshino M; Ohtake A; Yorifuji T; Tsukahara H; Hirayama S; Miida T; Fukui M; Okano Y
    Mol Genet Metab; 2011 Jul; 103(3):220-5. PubMed ID: 21514861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterol changes along with cholesterol and vitamin D changes in adult phenylketonuric patients diagnosed by newborn mass-screening.
    Nagasaka H; Okano Y; Kimura A; Mizuochi T; Sanayama Y; Takatani T; Nakagawa S; Hasegawa E; Hirano K; Mochizuki H; Ohura T; Ishige-Wada M; Usui H; Yorifuji T; Tsukahara H; Hirayama S; Ohtake A; Yamato S; Miida T
    Clin Chim Acta; 2013 Feb; 416():54-9. PubMed ID: 23168022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cholesterol in adults with phenylketonuria.
    Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR
    Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).
    Huemer M; Simma B; Mayr D; Möslinger D; Mühl A; Schmid I; Ulmer H; Bodamer OA
    J Inherit Metab Dis; 2012 Sep; 35(5):817-21. PubMed ID: 22290024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal serum phenylalanine for adult patients with phenylketonuria (PKU).
    Hanley WB
    Mol Genet Metab; 2013 Nov; 110(3):199-200. PubMed ID: 24090705
    [No Abstract]   [Full Text] [Related]  

  • 9. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
    Kanzelmeyer N; Tsikas D; Chobanyan-Jürgens K; Beckmann B; Vaske B; Illsinger S; Das AM; Lücke T
    Amino Acids; 2012 May; 42(5):1765-72. PubMed ID: 21472412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of lipoproteins in phenylalanine hydroxylase-deficient children during the first year of life.
    Nagasaka H; Tsukahara H; Okano Y; Hirano K; Sakurai T; Hui SP; Ohura T; Usui H; Yorifuji T; Hirayama S; Ohtake A; Miida T
    Clin Chim Acta; 2014 Jun; 433():1-4. PubMed ID: 24607329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria.
    Palaiodimou L; Zompola C; Lachanis S; Mylona V; Theodorou A; Papagiannopoulou G; Kotsali-Peteinelli V; Foska A; Kasti A; Skouma A; Tsivgoulis G
    Neurologist; 2020 Dec; 26(1):20-21. PubMed ID: 33394907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased serum ubiquinone-10 concentrations in phenylketonuria.
    Artuch R; Vilaseca MA; Moreno J; Lambruschini N; Cambra FJ; Campistol J
    Am J Clin Nutr; 1999 Nov; 70(5):892-5. PubMed ID: 10539751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview.
    Verduci E; Banderali G; Moretti F; Lassandro C; Cefalo G; Radaelli G; Salvatici E; Giovannini M
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):171-7. PubMed ID: 26708644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria.
    Artuch R; Colomé C; Vilaseca MA; Sierra C; Cambra FJ; Lambruschini N; Campistol J
    J Inherit Metab Dis; 2001 Jun; 24(3):359-66. PubMed ID: 11486901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.
    Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D
    Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.